Welcome to our dedicated page for NUCOR SEC filings (Ticker: NUE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on NUCOR's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into NUCOR's regulatory disclosures and financial reporting.
Nucor Corporation executive vice president Kenneth Rex Query sold common stock in an open-market transaction. On February 11, 2026, he sold 7,452 shares of Nucor common stock at a weighted average price of $196.0194 per share, with individual trades occurring between $195.9501 and $196.3350. After this sale, he directly owned 76,628 shares of Nucor common stock.
Nucor Corporation has a holder planning to sell 7,452 shares of its common stock under Rule 144. The shares are to be sold through Merrill Lynch on the NYSE, with an aggregate market value of 1,460,438.41 and 228,858,659 shares outstanding.
The securities were acquired as restricted stock compensation from Nucor on 06/01/2024, in three grants totaling 7,452 shares, with payment also dated 06/01/2024. The notice states the seller represents they do not know of any undisclosed material adverse information about Nucor’s operations.
Nucor Corporation Executive Vice President Allen C. Behr reported option exercises and share sales in Nucor (NUE) stock. On February 2, 2026, he exercised 7,500 stock options at an exercise price of $42.46 per share and sold 7,500 common shares at $181.0701 per share.
On February 3, 2026, he exercised another 7,568 stock options at $42.46 and sold 7,568 common shares at a weighted average price of $188.4983, with individual sale prices ranging from $188.400 to $188.775. After these transactions, he directly owned 67,711.16 Nucor common shares.
An insider for issuer symbol NUE has filed a Rule 144 notice to sell 7,568 common shares on the NYSE through Fidelity Brokerage Services. The filing lists 228,858,659 common shares outstanding and shows that these shares were acquired via an option granted in 2020 and paid for in cash on 02/03/2026.
Over the prior three months, the same seller, Allen Behr, reported sales of 5,950 common shares on 12/19/2025 for $939,445.50 and 7,500 common shares on 02/02/2026 for $1,358,025.75. By signing, the seller represents not knowing undisclosed material adverse information about the issuer.
Nucor Corporation executive Daniel R. Needham, an Executive Vice President, reported selling 3,881 shares of Nucor common stock on January 30, 2026 at a price of $178 per share. After this transaction, he beneficially owns 88,298.37 shares of Nucor common stock held directly.
Nucor Corporation shareholder Allen Behr has filed a Notice of Proposed Sale of Securities under Rule 144 to sell 7,500 shares of Nucor common stock. The planned sale is to be executed through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $1,358,025.75 and 228,858,659 shares of common stock reported as outstanding.
The 7,500 shares were acquired for cash on 02/02/2026 through an option originally granted on 06/01/2020. The filing also reports that Behr sold 5,950 Nucor common shares on 12/19/2025 for gross proceeds of $939,445.50 during the prior three months.
An insider of NUE filed a notice of proposed sale under Rule 144 to sell 3,881 shares of common stock, with an aggregate market value of $690,818.00. The shares are to be sold through Fidelity Brokerage Services LLC on or around January 30, 2026 on the NYSE.
The securities were originally acquired on June 1, 2025 through restricted stock vesting from the issuer as compensation. The filing notes that 228,858,659 shares of this class were outstanding, providing context for the size of the planned sale.
Nucor Corporation filed a current report to note that it released its financial results for the quarter ended December 31, 2025. The company issued a news release on January 26, 2026 and furnished it as Exhibit 99.1. On the same day, Nucor also posted an investor presentation on its Investor Relations website and furnished that presentation as Exhibit 99.2.
The company states that the information in this report and its exhibits is being furnished rather than filed, which limits certain legal liabilities and controls whether it is automatically incorporated into other SEC filings.
Nucor Corporation executive vice president reported personal stock transactions in company shares. On 12/23/2025, the officer reported a sale of 2,000 shares of Nucor common stock at $165.275 per share under transaction code S. A separate disposition of 593 shares was reported at a price of $0 per share under transaction code G. Following these transactions, the officer beneficially owned 17,358.87 shares of Nucor common stock, held directly.
NUE has a Form 144 notice indicating a proposed sale of 2,000 shares of its common stock through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $330,550.00. The filing states that 228,858,659 shares of this class of stock are outstanding. The seller plans the transaction around 12/23/2025.
The 2,000 common shares to be sold were acquired on 03/10/2024 from the issuer as compensation, with the date of payment also listed as 03/10/2024 and the nature of payment described as compensation. By signing, the seller represents that they are not aware of any undisclosed material adverse information about NUE’s current or prospective operations.